Trial Profile
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jun 2021
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Shire
- 05 Apr 2013 New source identified and integrated (United Kingdom Clinical Research Network; 12598).
- 12 Jan 2013 Planned number of patients changed from 30 to 64 as reported by European Clinical Trials Database.
- 12 Jan 2013 New source identified and integrated (EudraCT2011-000164-10: European Clinical Trials Database).